Previous studies have left unanswered whether human obesity, independent of glucose intolerance, is associated with a "postreceptor" defect in insulin action. We have studied the relationship between the degree of obesity (as estimated by underwater weighing) and the maximal insulin-stimulated glucose disposal rate (M) in vivo in 52 glucose-tolerant Pima Indian males. The relationship was examined independently of differences in age and maximal oxygen uptake (an estimate of "physical fitness"). The maximal insulin-stimulated glucose transport rate (MTR) was also measured in isolated abdominal adipocytes from the same subjects to determine whether differences in M could be explained by differences in glucose transport. The results showed that there was a large variance in M and MTR among these glucose-tolerant subjects. M was better correlated with glucose storage rates than with oxidation rates, as estimated by indirect calorimetry. The most obese subjects had only a 20% lower mean M and 30% lower MTR than the most lean subjects. The lower M in the obese subjects was due to both lower glucose oxidation and storage rates. There was no significant, independent correlation between age or degree of obesity and M or MTR. The maximal oxygen uptake (VO2 max) appeared to independently account for 20% of the variance observed in M. MTR was only weakly correlated with M (r = 0.36, P less than […] Abstract. Previous studies have left unanswered whether human obesity, independent of glucose intolerance, is associated with a "postreceptor" defect in insulin action. We have studied the relationship between the degree ofobesity (as estimated by underwater weighing) and the maximal insulin-stimulated glucose disposal rate (M) in vivo in 52 glucose-tolerant Pima Indian males. The relationship was examined independently of differences in age and maximal oxygen uptake (an estimate of"physical fitness"). The maximal insulin-stimulated glucose transport rate (MTR) was also measured in isolated abdominal adipocytes from the same subjects to determine whether differences in M could be explained by differences in glucose transport. The results showed that there was a large variance in M and MTR among these glucosetolerant subjects. M was better correlated with glucose storage rates than with oxidation rates, as estimated by indirect calorimetry. The most obese subjects had only a 20% lower mean M and 30% lower MTR than the most lean subjects. The lower M in the obese subjects was due to both lower glucose oxidation and storage rates. There was no significant, independent correlation between age or degree ofobesity and M or MTR. The maximal oxygen uptake (VO2 max) appeared to independently account for 20% of the variance observed in M. MTR was only weakly correlated with M (r = 0.36, P < 0.02). We concluded that differences in M in these glucose-tolerant subjects must be explained by factor(s) other than maximal oxygen uptake, age, maximal insulin-stimulated glucose transport in vitro, or degree of adiposity per se.
Introduction
The hyperinsulinemic, euglycemic clamp technique, performed at supraphysiologic insulin concentrations, has been used to assess postbinding steps in insulin action in man in vivo (1, 2, 3) . By using this technique, Kolterman et al. (1) have reported decreased in vivo maximal insulin-stimulated glucose utilization rates in obese compared with lean subjects. In contrast, DeFronzo (2) reported that in vivo maximal insulin-stimulated glucose utilization rates were similar between lean and obese subjects. A possible explanation for the different results was that Kolterman et al. studied obese subjects with or without glucose intolerance (4), whereas DeFronzo studied only glucose-tolerant subjects. Olefsky et al. (5) have also reported a significant association between decreased maximal insulin-stimulated glucose utilization rates in vivo and in vitro in isolated abdominal adipocytes from obese subjects with and without glucose intolerance.
The present study was designed to provide additional data regarding the relationship between obesity and maximal insulinstimulated glucose utilization rates in vivo and in vitro. In male Pima Indians, obesity was estimated by densitometry, in vivo maximal insulin-stimulated glucose disposal was measured by using the euglycemic clamp technique, and in vitro maximal insulin action was determined in isolated abdominal adipocytes from the same subjects. To minimize differences in glucose tolerance as a possible confounding variable in the analysis of the relationship between obesity and insulin action, only Indians with normal glucose tolerance were studied. The relationship between obesity and insulin action in vivo and in vitro was defined independently of other factors that may effect insulin action, such as age (6) and maximal oxygen uptake (7) , an estimate of "physical fitness." Methods Subjects. Physically untrained, male Pima Indians of the Gila River Indian Reservation who had previously been examined as part of an ongoing epidemiological study ofthe reservation population were asked to volunteer for the study. After written informed consent was obtained, amined, and a 12-lead electrocardiogram recorded. After an overnight fast, blood was drawn for complete blood count, liver function tests, blood-urea nitrogen, creatinine, electrolytes, calcium, total protein, and albumin. After at least 2 d of a weight-maintaining diet containing more than 200 g of carbohydrate, an oral glucose tolerance test was performed (4). Only the results of subjects with a normal physical examination, electrocardiogram, screening blood tests, and normal glucose tolerance (4) are reported. The characteristics of the 52 study subjects are shown in Table I .
Body composition. The percent body fat of each volunteer was estimated by underwater weighing with correction for the simultaneously measured residual lung volume (8) .
In vitro glucose transport in isolated adipocytes. After at least 3 d of the weight-maintaining diet, and after a 12-h overnight fast, subcutaneous adipose tissue was removed from the lateral aspect of the hypogastrium, inferior to the umbilicus (McBurney's point), and isolated adipocytes were prepared by collagenase digestion as described previously in detail (9) . Three subjects refused the biopsy so that adipocyte data is available on 49 of the 52 subjects. Adipose cell size was determined by sizing osmium-fixed cells on Coulter Electronic Cell counter (Coulter Electronics, Inc., Hialeah, FL) equipped with logarithmic range-expanded channelyzer as described previously (9) . We have measured maximal insulin-stimulated glucose transport by a new method, the verification of which has been reported previously (9) for obese subjects. We Indirect calorimetry. 1 h before the start of the insulin infusions, a clear, plastic, ventilated hood was placed over the subject's head. Room air was drawn through the hood and the flow rate measured by a pneumotachograph (Gould, Cleveland, Ohio). A constant fraction of expired air was withdrawn and analyzed for oxygen and carbon dioxide content. The oxygen analyzer was a zirconium cell analyzer (Applied Electrochemistry, Sunnyvale, CA) and the carbon dioxide analyzer was an infrared analyzer (Applied Electrochemistry). The analyzers and flowmeter were connected to a desktop computer (Hewlett-Packard Co., Palo Alto, CA). This recorded continuous, integrated calorimetric measurements every 5 min for the hour before and for the duration of the euglycemic clamp. The protein oxidation during the test was estimated from the urinary urea production rate. The nonprotein respiratory quotient was then calculated and the substrate oxidation rates determined from the tables of Lusk (10) .
Maximal oxygen uptake determinations. A graded exercise test was performed the day after the euglycemic clamp procedure by using intermittent work-bouts on a treadmill. Each test was started at 0 degrees elevation and involved walking at 1.5 mph. The elevation and speed of the treadmill were gradually increased. After 4 min at each work level, the subject sat down until the heart rate was <120 beats per minute and he had subjectively recovered. The test continued until the patient was subjectively exhausted, the heart rate reached 200 beats per minute, or there was no further increase in the oxygen uptake (VO2)' (1 , 12) .
The oxygen uptake was determined during the last 30 s to 1 min of each work-bout. The subject was connected to a low-resistance mouthpiece or "J" valve (Warren E. Collins, Inc., Braintree, MA). After 1 min ofadaptation, the expired air was collected in a 120-liter Tissot spirometer (Warren E. Collins, Inc.). During the collection period, a sample of expired air was continuously drawn and analyzed for oxygen and carbon dioxide as described above. The average fraction of 02 and C02, the minute ventilation, oxygen uptake, CO2 production, and respiratory quotient were calculated by an on-line Hewlett Packard 85 computer and printed out at the end of each collection. V02 max was defined as the highest V02 recorded during the exercise test.
Calculations. The appearance rate (Ra) of glucose in the plasma during the euglycemic clamp was calculated from the blood [3-H3Jglucose specific activities by using the nonsteady state equations of Steele ( 13) .
The endogenous glucose production rate equals the difference between the rate of exogenous glucose infusion and the Ra determined from Steele's equations. If the Ra was equal to or less than the exogenous glucose infusion rate, the endogenous glucose production rate was as-1. Abbreviations used in this paper: M, total maximal insulin-stimulated glucose disposal; MTR, maximal insulin-stimulated glucose transport by isolated adipocytes; V02, oxygen uptake.
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Obesity and Maximal Insulin Action sumed to be completely suppressed. In this study, this occurred in all subjects so that the total glucose disposal rate = exogenous glucose infusion rate. The mean exogenous glucose infusion rate was calculated for each 20 min between 160-200 min during the euglycemic clamp and then averaged to calculate the mean glucose disposal rate or "M" value. The insulin-stimulated carbohydrate oxidation rates were calculated from the indirect calorimetric data by averaging the data for the last 40 min of the insulin infusion, i.e., also from 160 to 200 min during the euglycemic clamp. The carbohydrate storage rate was estimated by subtracting the carbohydrate oxidation rate from the mean total glucose disposal rate.
Analytical methods. The plasma glucose concentration was measured by the glucose oxidase method by using a Beckman glucose analyzer (Beckman Instruments, Inc., Fullerton, CA). Plasma insulin concentrations were determined by the Herbert modification (14) of the radioimmunoassay of Berson and Yalow (15) . The tritiated glucose specific activity in blood samples was performed as described by others ( 16) by using perchloric acid to precipitate the protein.
Statistics. All data are expressed as the means±SEM. All statistical analyses were calculated by using statistical analysis system (SAS Institute, Inc., Cary, NC). Simple correlations are Person product moment correlations and partial correlations were calculated using the SAS general linear models procedure.
Results
The 
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Bogardus, Lillioja, Mott, Reaven, Kashiwagi, and Foley = -0.40, P < 0.005). M was better correlated with the glucose storage rate (r = 0.93, P < 0.001) than with oxidation rates (r = 0.66, P < 0.001). Percent body fat was weakly correlated with the maximally insulin-stimulated glucose oxidation rate (r = -0.39, P < 0.05) and the glucose storage rates (r = -0.30, P < 0.02). However, there was no significant linear correlation between MTR and percent body fat (Fig. 1 B) .
To further evaluate the effect of obesity on maximal insulinstimulated glucose disposal in vivo and on glucose transport in vitro, we formed two extreme groups of the most lean (mean percent body fat = 13±1%) and the most obese subjects (mean percent body fat = 38±1%). The lean group (n = 10) consisted of subjects with a percent body fat <20%, and comprised 10 individuals. There were 20 subjects in the obese group, all with a percent body fat >32%. The results of these comparisons are seen in Fig. 2 , and the data in the left panel indicate M was reduced by about 20% in the most obese group. Although this was a small difference, it was statistically significant (P < 0.05). Further inspection of the data in the left panel shows that this difference was due to a reduction in both the mean glucose oxidation and storage rate. The mean reduction in MTR in adipocytes isolated from the obese group were actually greater than the fall in M value, but because of the large individual variance, this effect of obesity was of marginal significance (P = 0.11) (Fig. 2 B) .
Maximal oxygen uptake was determined in 37 of the 52 subjects and the relationship between V02 max and M is shown in Fig. 3 . There was a significant positive linear correlation between V02 max and M (r = 0.56, P < 0.001). Similarly, V02 max correlated positively with the insulin-stimulated glucose most lean subjects (mean percent body fat = 13±1%). (Right) Comparison of the maximal insulin-stimulated glucose transport rate in isolated adipocytes from the same subjects. The glucose transport rate is expressed as femtoliters per second per cell. *Significant difference between groups (P < 0.05) in glucose oxidation rates. tSignificant difference between groups (P < 0.05) in glucose storage rates. **Significant difference between groups (P < 0.05) in the total glucose disposal rate. ffm, fat-free mass. 'U/ml. oxidation rate (r = 0.51, P < 0.002) and glucose storage rate (r = 0.47, P < 0.005). However, no correlation was seen between V02 max and MTR in vitro in isolated adipocytes. The mean V02 max of the 20 most obese subjects was significantly (P < 0.05) lower than that of the 10 most lean subjects, 48.2±1.0 ml 02/kg fat-free mass per min vs. 52.7±1.5 ml 02/kg fat-free mass per min, respectively.
Increasing age was negatively correlated with total M (r --0.32, P < 0.02). Age was also significantly negatively correlated with the glucose storage rate (r =-0.30, P < 0.04), but not with the glucose oxidation rate (r = -0.20, P = 0.17). The MTR in vitro did not significantly correlate with age.
The linear correlations between percent body fat, V02 max, and age, and the measures of insulin action were then examined by partial correlation analyses. These analyses were done only on the 37 subjects for whom there was data for M, percent body fat, and V02 max.
These results are seen in Table III , and the important conclusions can be drawn from these data. First, it is apparent that the simple correlation coefficients between percent body fat and either V02 max, age, and in vivo insulin action declined when the individual correlations were adjusted for the effect of the other two variables. Secondly, it can be seen that only the V02 max remained significantly correlated with the measures of in vivo insulin action after these adjustments were made. Thus, neither obesity nor age appear to be independently correlated with in vivo maximal insulin-stimulated glucose disposal, storage, or oxidation rate.
The relationship between the MTR of glucose by isolated adipocytes and the M value in vivo is shown in Fig. 4 . There was a weak, positive linear correlation between these in vitro and in vivo estimates of insulin action (r = 0.36, P < 0.02). These results are in contrast with previously reported experimental data (1, 5) . However, the characteristics ofthe subjects in the previous studies and ours are different. We s N Õ ** * 0 e s storage, and oxidation, which was independent ofage or obesity. Given these findings, and an earlier report of an independent correlation between V02 max and M at lower insulin concentrations (7), it is apparent that previous estimates of the deleterious effect of obesity on insulin action may have been confounded by the fact that obese subjects frequently have lower maximal oxygen uptake rates compared with lean subjects.
Although it was not the purpose of the current study, we observed a large variance in the individual values for M and MTR of the 52 Pima males who make up the study population. This may help explain why we observed only a very weak correlation between M and MTR. This weak correlation contrasts with a previous report (5) that showed a good correlation between these parameters in a smaller group oflean and obese Caucasians. Again, differences in the glucose tolerance of the subjects in the two studies may be the reason for the different results. In addition, since there is such a large variance in M in obese subjects, different results may be obtained depending on the subgroup studied. The weak correlation between in vitro glucose transport and in vivo glucose disposal should not be interpreted, however, as evidence that glucose transport cannot be an important "postreceptor" rate-limiting step for insulin action in vivo. It has been shown previously that diabetic patients have lower in vitro glucose transport rates and M's than glucose-tolerant, weightmatched subjects and that both parameters are increased following insulin therapy (9, 19, 20, 21) , suggesting that transport may be an important rate-limiting step for insulin action in vivo under some conditions.
In conclusion, we were able to account for very little of the variance observed in the maximal insulin-stimulated glucose disposal rate in vivo in glucose-tolerant subjects. The cause of this variance in insulin action, at these maximally stimulating insulin concentrations, remains largely unexplained. Our data suggest that further studies to define "postreceptor" defects in insulin action in vivo should focus on the cause of a decreased glucose storage rate rather than differences in oxidation rates, since M has more highly correlated with insulin-stimulated glucose storage rates than with glucose oxidation rates.
